BIO-key International (BKYI)
Market Price (5/14/2026): $3.06 | Market Cap: $2.0 MilSector: Industrials | Industry: Security & Alarm Services
BIO-key International (BKYI)
Market Price (5/14/2026): $3.06Market Cap: $2.0 MilSector: IndustrialsIndustry: Security & Alarm Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -22% Megatrend and thematic driversMegatrends include Cybersecurity. Themes include Identity Management. | Weak multi-year price returns2Y Excs Rtn is -119%, 3Y Excs Rtn is -177% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -3.9 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -61% Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -13%, Rev Chg QQuarterly Revenue Change % is -28% Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -53%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -53% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -164% High stock price volatilityVol 12M is 104% Key risksBKYI key risks include [1] a high probability of financial distress stemming from consistent unprofitability and a short cash runway, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -22% |
| Megatrend and thematic driversMegatrends include Cybersecurity. Themes include Identity Management. |
| Weak multi-year price returns2Y Excs Rtn is -119%, 3Y Excs Rtn is -177% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -3.9 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -61% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -13%, Rev Chg QQuarterly Revenue Change % is -28% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -53%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -53% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -164% |
| High stock price volatilityVol 12M is 104% |
| Key risksBKYI key risks include [1] a high probability of financial distress stemming from consistent unprofitability and a short cash runway, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Nasdaq Delisting Due to Non-Compliance. BIO-key International's stock was suspended from trading on the Nasdaq Capital Market effective May 12, 2026, and subsequently moved to the OTC Markets. This suspension was triggered by the company's failure to maintain a minimum bid price of $1 for the required ten consecutive trading days by the May 4 deadline, as well as its inability to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This delisting significantly reduces the stock's liquidity and investor visibility, contributing to a negative market perception.
2. Ineffective Reverse Stock Split. The company implemented a 1-for-10 reverse stock split, effective April 30, 2026, which was approved by stockholders on April 20, 2026. This measure was primarily intended to help BIO-key regain compliance with Nasdaq's $1 minimum bid price requirement. However, despite this action, the stock failed to hold the minimum bid price for the necessary period, ultimately leading to the delisting. Reverse stock splits are often viewed negatively by investors as they can signal underlying financial difficulties rather than fundamental improvements.
Show more
Stock Movement Drivers
Fundamental Drivers
The -44.3% change in BKYI stock from 1/31/2026 to 5/13/2026 was primarily driven by a -44.3% change in the company's P/S Multiple.| (LTM values as of) | 1312026 | 5132026 | Change |
|---|---|---|---|
| Stock Price ($) | 7.25 | 4.04 | -44.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 6 | 6 | 0.0% |
| P/S Multiple | 0.8 | 0.4 | -44.3% |
| Shares Outstanding (Mil) | 1 | 1 | 0.0% |
| Cumulative Contribution | -44.3% |
Market Drivers
1/31/2026 to 5/13/2026| Return | Correlation | |
|---|---|---|
| BKYI | -44.3% | |
| Market (SPY) | 7.6% | 5.3% |
| Sector (XLI) | 5.2% | -5.8% |
Fundamental Drivers
The -48.2% change in BKYI stock from 10/31/2025 to 5/13/2026 was primarily driven by a -35.9% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 5132026 | Change |
|---|---|---|---|
| Stock Price ($) | 7.80 | 4.04 | -48.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7 | 6 | -8.6% |
| P/S Multiple | 0.7 | 0.4 | -35.9% |
| Shares Outstanding (Mil) | 1 | 1 | -11.6% |
| Cumulative Contribution | -48.2% |
Market Drivers
10/31/2025 to 5/13/2026| Return | Correlation | |
|---|---|---|
| BKYI | -48.2% | |
| Market (SPY) | 9.5% | 0.4% |
| Sector (XLI) | 12.7% | -0.5% |
Fundamental Drivers
The -49.8% change in BKYI stock from 4/30/2025 to 5/13/2026 was primarily driven by a -53.6% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 4302025 | 5132026 | Change |
|---|---|---|---|
| Stock Price ($) | 8.04 | 4.04 | -49.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7 | 6 | -8.9% |
| P/S Multiple | 0.4 | 0.4 | 18.6% |
| Shares Outstanding (Mil) | 0 | 1 | -53.6% |
| Cumulative Contribution | -49.8% |
Market Drivers
4/30/2025 to 5/13/2026| Return | Correlation | |
|---|---|---|
| BKYI | -49.8% | |
| Market (SPY) | 35.4% | 9.7% |
| Sector (XLI) | 34.1% | 6.6% |
Fundamental Drivers
The -96.6% change in BKYI stock from 4/30/2023 to 5/13/2026 was primarily driven by a -93.1% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 4302023 | 5132026 | Change |
|---|---|---|---|
| Stock Price ($) | 118.80 | 4.04 | -96.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 6 | 6 | 1.9% |
| P/S Multiple | 0.9 | 0.4 | -51.5% |
| Shares Outstanding (Mil) | 0 | 1 | -93.1% |
| Cumulative Contribution | -96.6% |
Market Drivers
4/30/2023 to 5/13/2026| Return | Correlation | |
|---|---|---|
| BKYI | -96.6% | |
| Market (SPY) | 85.5% | 6.9% |
| Sector (XLI) | 81.6% | 2.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| BKYI Return | -37% | -74% | -72% | -43% | -68% | -36% | -99% |
| Peers Return | -12% | -41% | 8% | 19% | 1% | 12% | -25% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 8% | 97% |
Monthly Win Rates [3] | |||||||
| BKYI Win Rate | 33% | 33% | 33% | 33% | 33% | 20% | |
| Peers Win Rate | 49% | 30% | 45% | 52% | 48% | 48% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 60% | |
Max Drawdowns [4] | |||||||
| BKYI Max Drawdown | -39% | -76% | -74% | -80% | -68% | -36% | |
| Peers Max Drawdown | -24% | -56% | -25% | -21% | -24% | -21% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: OKTA, YOU, OSPN, MITK, AWRE.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/13/2026 (YTD)
How Low Can It Go
| Event | BKYI | S&P 500 |
|---|---|---|
| 2024 Yen Carry Trade Unwind | ||
| % Loss | -24.7% | -7.8% |
| % Gain to Breakeven | 32.8% | 8.5% |
| Time to Breakeven | 26 days | 18 days |
| 2020 COVID-19 Crash | ||
| % Loss | -47.6% | -33.7% |
| % Gain to Breakeven | 90.9% | 50.9% |
| Time to Breakeven | 10 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -49.0% | -19.2% |
| % Gain to Breakeven | 96.0% | 23.7% |
| Time to Breakeven | 31 days | 105 days |
| 2013 Taper Tantrum | ||
| % Loss | -17.2% | -0.2% |
| % Gain to Breakeven | 20.8% | 0.2% |
| Time to Breakeven | 28 days | 1 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -26.2% | -17.9% |
| % Gain to Breakeven | 35.4% | 21.8% |
| Time to Breakeven | 6 days | 123 days |
| 2010 Eurozone Sovereign Debt Crisis / Flash Crash | ||
| % Loss | -50.0% | -15.4% |
| % Gain to Breakeven | 100.0% | 18.2% |
| Time to Breakeven | 8 days | 125 days |
In The Past
BIO-key International's stock fell -24.7% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 32.8% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | BKYI | S&P 500 |
|---|---|---|
| 2024 Yen Carry Trade Unwind | ||
| % Loss | -24.7% | -7.8% |
| % Gain to Breakeven | 32.8% | 8.5% |
| Time to Breakeven | 26 days | 18 days |
| 2020 COVID-19 Crash | ||
| % Loss | -47.6% | -33.7% |
| % Gain to Breakeven | 90.9% | 50.9% |
| Time to Breakeven | 10 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -49.0% | -19.2% |
| % Gain to Breakeven | 96.0% | 23.7% |
| Time to Breakeven | 31 days | 105 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -26.2% | -17.9% |
| % Gain to Breakeven | 35.4% | 21.8% |
| Time to Breakeven | 6 days | 123 days |
| 2010 Eurozone Sovereign Debt Crisis / Flash Crash | ||
| % Loss | -50.0% | -15.4% |
| % Gain to Breakeven | 100.0% | 18.2% |
| Time to Breakeven | 8 days | 125 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -66.7% | -53.4% |
| % Gain to Breakeven | 200.0% | 114.4% |
| Time to Breakeven | 133 days | 1085 days |
In The Past
BIO-key International's stock fell -24.7% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 32.8% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About BIO-key International (BKYI)
AI Analysis | Feedback
Here are a few analogies for BIO-key International (BKYI):
- Like Okta, but specialized in identity access management with fingerprint biometrics.
- Imagine Okta, but they also provide the fingerprint scanners for secure access.
AI Analysis | Feedback
- BIO-key PortalGuard and PortalGuard IDaaS Solutions: A cloud-based identity platform providing identity access management, SaaS application integration, and Windows device authentication.
- BIO-key VST: A product offering fingerprint identification biometric technology.
- WEB-key: A product offering fingerprint identification biometric technology.
- Civil and Large-Scale ID Infrastructure Solutions: Services focused on developing finger-based biometric technology for large-scale identification projects.
- Finger Scanners (SideSwipe, EcoID, SidePass): Hardware devices for fingerprint identification marketed to enterprise and consumer segments.
AI Analysis | Feedback
nullAI Analysis | Feedback
null
AI Analysis | Feedback
Michael W. DePasquale, Chairman and Chief Executive Officer
Michael W. DePasquale has served as Chief Executive Officer of BIO-key International since January 2003 and as Chairman of the Board since February 2014. He brings over 25 years of executive management, sales, and marketing experience to the company. Prior to joining BIO-key, he was President and CEO of Prism eSolutions, Inc., a provider of professional consulting services. He also served as Group Vice President for WRC Media, a distributor of supplemental education products and software. From 1996 to 1999, he was Senior Vice President of Jostens Learning Corporation, a multimedia curriculum provider that was acquired by WRC Media. DePasquale was part of a team, along with GE Capital and Bain Partners, that purchased Jostens Learning in 1996. He previously held sales and marketing management positions with McGraw-Hill and Digital Equipment Corporation.
Cecilia Welch, Chief Financial Officer
Cecilia Welch has been the Chief Financial Officer of BIO-key International since 2009. She also holds the title of Principal Accounting Officer. Welch has over 25 years of operational and financial management experience in various technology corporations. Before her tenure at BIO-key, she was Controller for SavaJe Technologies, Crystal Systems, and ATN Microwave. ATN Microwave was later acquired by Agilent Technologies. She also served as Secretary & Director at ATE Systems, Inc.
Mira LaCous, Chief Technology Officer
Mira LaCous serves as the Chief Technology Officer at BIO-key International. In this role, she is responsible for steering the development of the company's biometric and Identity Access Management (IAM) product lines, including PortalGuard.
James Sullivan, Chief Legal Officer
James Sullivan is the Chief Legal Officer of BIO-key International. He also holds the position of Senior Vice President of Strategy & Compliance.
Kelvin Wong, Managing Director – Hong Kong and Vice Chairman of the Board of Directors
Kelvin Wong is the Managing Director for BIO-key International's Hong Kong operations and also serves as the Vice Chairman of the Board of Directors. He is noted as a substantial investor in the company.
AI Analysis | Feedback
```html
- Intense Competition and Rapid Technological Advancements: BIO-key International operates in the dynamic and highly competitive market for fingerprint identification biometric technology and identity access management solutions. The continuous emergence of new technologies, such as advanced biometric modalities (e.g., facial or iris recognition), alternative authentication methods, or more sophisticated IAM platforms from competitors, poses a significant risk. Failure to innovate, keep pace with technological advancements, or differentiate its offerings could lead to a loss of market share and diminished demand for its solutions and finger scanners.
- Data Security and Privacy Risks: As a provider of identity access management solutions and fingerprint identification technology, BIO-key International handles sensitive biometric and personal identity data for its commercial, government, and education customers. A data breach, cyberattack, or perceived security vulnerability in its systems or products could result in severe reputational damage, loss of customer trust, significant financial liabilities, and regulatory penalties, directly impacting its ability to secure new contracts and retain existing clients.
- Reliance on Fingerprint Technology and Potential Market Shifts: While BIO-key offers broader identity access management solutions, its foundational technology and branded products (SideSwipe, EcoID, SidePass) are heavily centered around fingerprint identification and scanning. A shift in industry preference towards other biometric modalities, evolving security concerns surrounding fingerprint data, or the widespread adoption of non-biometric advanced authentication methods could reduce the demand for BIO-key's core fingerprint-based offerings. This could necessitate substantial investment in diversification or risk making a significant portion of its product portfolio less competitive.
AI Analysis | Feedback
A clear emerging threat for BIO-key International is the rapid diversification and increasing adoption of alternative biometric modalities such as facial recognition, iris scanning, and behavioral biometrics. Given BIO-key's strong emphasis on "fingerprint identification biometric technology" and "finger scanners" in its core offerings, a widespread shift towards these alternative methods, often natively integrated into devices and platforms by major technology companies, could diminish demand for dedicated fingerprint solutions and impact their specialized technology and hardware products.AI Analysis | Feedback
BIO-key International (symbol: BKYI) operates within several significant addressable markets, primarily focusing on biometric technology, identity access management (IAM) solutions, and fingerprint scanners.
Biometric Technology Market
The global biometric technology market, which encompasses fingerprint identification biometric technology and software solutions, as well as civil and large-scale ID infrastructure solutions, demonstrates substantial growth. In 2023, this market was valued at approximately USD 41.08 billion and is projected to reach USD 150.57 billion by 2030, growing at a compound annual growth rate (CAGR) of 20.4% from 2024 to 2030. Other projections estimate the market size at USD 46.52 billion in 2023, expected to reach USD 171.98 billion by 2033 with a CAGR of 13.97%. Another report valued the global market at USD 43.7 billion in 2025, with an expectation to reach USD 115.2 billion by 2032, exhibiting a CAGR of 15.3%. By 2025, the market is projected to be around USD 59.65 billion, exceeding USD 322.94 billion by 2035 with an 18.4% CAGR between 2026 and 2035.
North America held the largest share of the global biometric technology market, accounting for 30.4% of the revenue in 2023. The U.S. market within North America is projected to be a leading region, with an estimated market size of USD 17.0 billion in 2025 and is expected to reach USD 24.34 billion by 2030.
Identity and Access Management (IAM) Solutions Market
The global identity and access management (IAM) market, which includes solutions like BIO-key's PortalGuard and PortalGuard IDaaS, was estimated at USD 15.93 billion in 2022 and is projected to grow to USD 41.52 billion by 2030, at a CAGR of 12.6% from 2023 to 2030. More recent figures indicate the market was valued at USD 20.41 billion in 2024 and is projected to reach USD 65.70 billion by 2034, growing at a CAGR of 12.40% from 2025 to 2034. Other estimates place the global IAM market at USD 18.81 billion in 2024, with an anticipated rise to USD 72.08 billion by 2033 at a CAGR of 16.1% from 2026 to 2033. The market was also valued at USD 22.27 billion in 2025 and is projected to grow to USD 77.92 billion by 2034, exhibiting a CAGR of 15.10%.
North America is a dominant region in the IAM market, with a share of 37.22% and 40.30% in 2025. The North American IAM market size reached USD 7.55 billion in 2024 and is expected to attain approximately USD 24.31 billion by 2034. The U.S. identity and access management market alone was exhibited at USD 5.95 billion in 2025 and is projected to reach around USD 17.45 billion by 2034.
Fingerprint Scanner Market
The global fingerprint sensor market, where BIO-key offers products under brand names like SideSwipe, EcoID, and SidePass, was valued at USD 4.2 billion in 2024. This market is estimated to grow at a CAGR of 6.9% to reach USD 8.1 billion by 2034. Another estimate places the market size at USD 4.44 billion in 2025, expected to reach USD 8.44 billion by 2035, growing at a CAGR of 6.65% from 2026 to 2035. The global fingerprint scanner market specifically reached USD 2.41 billion in 2025 and is projected to expand to USD 4.80 billion by 2035, with a CAGR of 7.2% during the forecast period from 2026 to 2035.
The U.S. fingerprint sensor market accounted for USD 796.2 million in 2024. It was valued at USD 1.80 billion in 2025 and is expected to reach USD 3.42 billion by 2035, growing at a CAGR of 6.65% from 2026 to 2035. North America is considered the largest market for fingerprint scanners, holding approximately 40% of the global share.
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for BIO-key International (BKYI) over the next 2-3 years:
- Expansion in the Public Sector: BIO-key is strategically growing its presence in the government and education sectors. Recent contracts include the State of Wyoming Department of Education for its PortalGuard IDaaS platform, and new educational institutions adopting the same platform. Additionally, a partnership with TD SYNNEX Public Sector (DLT Solutions) aims to streamline procurement for U.S. federal, state, and local government agencies to deploy BIO-key's IAM and biometric solutions. The company is also seeing increased orders from the military and defense sector, with over $2 million in sales over the last 12 months, driven by its "BIO-key CyberDefense Initiative" in response to rising geopolitical tensions.
- Growth in the Financial Sector: BIO-key anticipates continued revenue growth from its banking and financial sector clients. A significant multi-year agreement with Sociedade Interbancária de Moçambique (SIMO) to modernize its national payments network marks BIO-key's eleventh banking customer globally. The company also secured a $1.04 million license renewal and expansion from a foreign retail bank in March 2026, which includes an anticipated 5% increase in client enrollment. There is also an expectation of a potential $3 million renewal from its largest customer in the first quarter of 2026.
- Increased Adoption of Identity-Bound Biometrics and Passwordless Solutions: A core driver is the increasing market acceptance and adoption of BIO-key's identity-bound biometrics and passwordless, phoneless, and tokenless authentication solutions. The company emphasizes that its biometric-centric multi-factor identity and access management (IAM) software secures access for over forty million users, providing a unique human basis for authentication that is highly resistant to phishing and credential sharing.
- International Market Expansion: BIO-key is actively expanding its global footprint, particularly in Europe, the Middle East, and Africa (EMEA). A notable contract win in Portugal to secure digital identities across a large municipal ecosystem signifies a meaningful expansion into the European public sector. The company's ramp-up of product sales in EMEA territories is also expected to contribute to revenue growth.
- New Product Launches and Platform Modernization: Innovation in its product offerings is expected to drive future revenue. BIO-key launched its next-generation EcoID III USB fingerprint scanner in Q3 2025. Furthermore, a significant platform modernization and deployment improvements for PortalGuard IDaaS are underway, with a targeted release in Q4 2025, and an updated PortalGuard identity platform is anticipated in late Q1 or early Q2 2026.
AI Analysis | Feedback
Share Repurchases
No significant share repurchases have been identified in the last 3-5 years.Share Issuance
- The number of outstanding shares significantly increased from 0.5 million in 2023 to 3.03 million in 2024, and further to 6.58 million in 2025.
- In October 2025, BIO-key received approximately $3.1 million in gross proceeds from an existing institutional investor exercising warrants to purchase 3,091,668 shares of common stock at $1.02 per share.
- In connection with the warrant exercise, the company also agreed to issue unregistered warrants to purchase an additional 6,183,336 shares of common stock.
Inbound Investments
- In September 2024, ARMISTICE CAPITAL, LLC acquired 250,000 shares of BIO-key International at a price of $0.9595 per share.
Outbound Investments
- In March 2022, BIO-key acquired Swivel Secure Europe, which significantly expanded its revenue base, customer reach, and talent across Europe, the Middle East, and Africa.
Capital Expenditures
- Capital expenditures were reported to be relatively low, with $1,000 invested in Q3 2025, representing a 10.4% decrease from the prior quarter.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| BIO-key International Earnings Notes | 12/16/2025 | |
| BIO-key International Stock Drop Looks Sharp, But How Deep Can It Go? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to BKYI.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 04302026 | GEO | GEO | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 04302026 | RUN | Sunrun | Special | Short Squeeze PotentialShort Squeeze PotentialHas potential for a short squeeze. High short interest, rising short interest and high debt. | 0.0% | 0.0% | 0.0% |
| 04172026 | RSG | Republic Services | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.8% | 0.8% | -1.1% |
| 04102026 | VRSK | Verisk Analytics | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 12.3% | 12.3% | 0.0% |
| 04102026 | OKTA | Okta | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 17.0% | 17.0% | 0.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 12.91 |
| Mkt Cap | 0.5 |
| Rev LTM | 218 |
| Op Inc LTM | 38 |
| FCF LTM | 46 |
| FCF 3Y Avg | 33 |
| CFO LTM | 53 |
| CFO 3Y Avg | 39 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 4.9% |
| Rev Chg 3Y Avg | 3.7% |
| Rev Chg Q | 4.8% |
| QoQ Delta Rev Chg LTM | 1.3% |
| Op Inc Chg LTM | 39.1% |
| Op Inc Chg 3Y Avg | 103.8% |
| Op Mgn LTM | 10.0% |
| Op Mgn 3Y Avg | 0.6% |
| QoQ Delta Op Mgn LTM | -0.2% |
| CFO/Rev LTM | 24.5% |
| CFO/Rev 3Y Avg | 18.7% |
| FCF/Rev LTM | 21.4% |
| FCF/Rev 3Y Avg | 16.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.5 |
| P/S | 2.6 |
| P/Op Inc | 15.9 |
| P/EBIT | 14.3 |
| P/E | 22.1 |
| P/CFO | 9.8 |
| Total Yield | 2.2% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 5.5% |
| D/E | 0.1 |
| Net D/E | -0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 6.6% |
| 3M Rtn | -0.7% |
| 6M Rtn | -6.4% |
| 12M Rtn | -24.4% |
| 3Y Rtn | -4.9% |
| 1M Excs Rtn | -0.6% |
| 3M Excs Rtn | -7.9% |
| 6M Excs Rtn | -15.2% |
| 12M Excs Rtn | -52.3% |
| 3Y Excs Rtn | -85.1% |
Price Behavior
| Market Price | $4.04 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 02/23/2007 | |
| Distance from 52W High | -60.8% | |
| 50 Days | 200 Days | |
| DMA Price | $5.83 | $6.89 |
| DMA Trend | down | down |
| Distance from DMA | -30.7% | -41.3% |
| 3M | 1YR | |
| Volatility | 107.0% | 104.5% |
| Downside Capture | 421.68 | 240.29 |
| Upside Capture | 151.27 | 88.50 |
| Correlation (SPY) | 5.2% | 8.6% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -1.28 | -0.45 | -0.21 | -0.11 | 0.63 | 0.60 |
| Up Beta | -3.78 | -3.62 | -2.38 | -4.56 | -1.17 | 0.06 |
| Down Beta | 2.76 | 0.72 | -0.11 | 1.19 | 2.02 | -0.29 |
| Up Capture | 34% | 21% | 14% | 45% | 48% | 28% |
| Bmk +ve Days | 15 | 22 | 31 | 66 | 141 | 428 |
| Stock +ve Days | 11 | 21 | 30 | 54 | 117 | 319 |
| Down Capture | 356% | 95% | 114% | 150% | 120% | 112% |
| Bmk -ve Days | 4 | 18 | 30 | 56 | 108 | 321 |
| Stock -ve Days | 11 | 22 | 34 | 71 | 134 | 414 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with BKYI | |
|---|---|---|---|---|
| BKYI | -49.6% | 104.3% | -0.21 | - |
| Sector ETF (XLI) | 25.5% | 15.3% | 1.28 | 5.6% |
| Equity (SPY) | 28.9% | 12.0% | 1.82 | 9.2% |
| Gold (GLD) | 44.6% | 26.8% | 1.35 | 1.6% |
| Commodities (DBC) | 47.8% | 18.6% | 1.96 | -1.1% |
| Real Estate (VNQ) | 11.3% | 13.5% | 0.55 | 5.0% |
| Bitcoin (BTCUSD) | -21.3% | 41.7% | -0.46 | 21.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with BKYI | |
|---|---|---|---|---|
| BKYI | -63.8% | 115.5% | -0.40 | - |
| Sector ETF (XLI) | 12.5% | 17.4% | 0.56 | 3.5% |
| Equity (SPY) | 13.7% | 17.1% | 0.63 | 7.0% |
| Gold (GLD) | 20.4% | 17.9% | 0.93 | 3.6% |
| Commodities (DBC) | 11.1% | 19.4% | 0.46 | 2.1% |
| Real Estate (VNQ) | 3.6% | 18.8% | 0.09 | 4.6% |
| Bitcoin (BTCUSD) | 7.5% | 55.9% | 0.35 | 4.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with BKYI | |
|---|---|---|---|---|
| BKYI | -51.1% | 127.0% | -0.13 | - |
| Sector ETF (XLI) | 14.1% | 20.0% | 0.62 | 0.7% |
| Equity (SPY) | 15.6% | 17.9% | 0.75 | 2.4% |
| Gold (GLD) | 13.4% | 15.9% | 0.70 | 1.4% |
| Commodities (DBC) | 8.3% | 17.9% | 0.38 | 0.5% |
| Real Estate (VNQ) | 5.4% | 20.7% | 0.22 | 0.2% |
| Bitcoin (BTCUSD) | 68.2% | 66.9% | 1.07 | 4.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 3/4/2026 | 0.9% | -6.1% | -24.3% |
| 11/14/2025 | -2.4% | -5.2% | -32.5% |
| 8/13/2025 | -2.0% | -5.0% | -6.6% |
| 3/27/2025 | -23.6% | -33.0% | -29.1% |
| 11/15/2024 | -7.8% | -18.0% | -8.3% |
| 6/17/2024 | 2.0% | -2.0% | 10.0% |
| 4/2/2024 | -7.4% | -16.2% | -23.6% |
| 10/25/2023 | -25.8% | -15.5% | -26.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 3 | 4 | 2 |
| # Negative | 16 | 15 | 17 |
| Median Positive | 2.0% | 1.2% | 7.8% |
| Median Negative | -6.5% | -14.2% | -23.6% |
| Max Positive | 3.5% | 10.1% | 10.0% |
| Max Negative | -25.8% | -35.3% | -49.4% |
Recent Forward Guidance [BETA]
Latest: Q1 2026 Earnings Reported 4/20/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q1 2026 Revenue | 2.20 Mil | 37.5% | Higher New | Actual: 1.60 Mil for Q1 2025 | |||
| Q2 2026 Revenue | 2.80 Mil | 64.7% | Higher New | Actual: 1.70 Mil for Q2 2025 | |||
| 2026 Revenue | 5.00 Mil | 51.5% | Higher New | Actual: 3.30 Mil for 2025 | |||
| 2026 Cash Position | 2.70 Mil | 0 | Same New | Actual: 2.70 Mil for 2025 | |||
Prior: Q4 2025 Earnings Reported 3/4/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Client Enrollment Growth | 5.0% | ||||||
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Depasquale, Michael W | Chief Executive Officer | Direct | Buy | 9172025 | 0.84 | 1,617 | 1,358 | 94,226 | Form |
| 2 | Depasquale, Michael W | Chief Executive Officer | Direct | Buy | 9172025 | 0.75 | 2,500 | 1,875 | 82,918 | Form |
| 3 | Sullivan, James David | Chief Legal Officer | Direct | Buy | 8262025 | 0.77 | 10,000 | 7,700 | 42,235 | Form |
| 4 | Depasquale, Michael W | Chief Executive Officer | Direct | Buy | 6162025 | 0.78 | 5,000 | 3,900 | 41,745 | Form |
| 5 | Depasquale, Michael W | Chief Executive Officer | Direct | Buy | 6042025 | 0.83 | 4,000 | 3,320 | 40,271 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.